You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
祥生醫療(688358.SH):與蓋茨基金會簽署聯合開發並推廣創新型產科及乳腺超聲篩查設備協議
格隆匯 07-22 15:35

格隆匯7月22日丨祥生醫療(688358.SH)公佈,公司於近日與蓋茨基金會簽署了關於聯合開發並推廣創新型產科及乳腺超聲篩查設備協議。

根據協議,蓋茨基金會將向公司提供合計210萬美元的項目資助,以支持公司開發並推廣創新型產科及乳腺超聲篩查設備。蓋茨基金會將根據項目研發目標/里程碑的達成情況,按約定的付款時間表分階段支付項目資金。

該項目產品旨在開發創新型超聲解決方案。通過在超聲設備上集成智能化的產前輔助篩查和乳腺病變篩查功能,利用智能化分析盲掃獲取的超聲視頻,實現智能識別產前及圍產期婦女的關鍵高危妊娠風險,準確評估胎兒健康狀況(如胎齡),高效完成婦女乳腺篩查,從而幫助中低收入國家的社區醫護人員、助產士羣體及其他非超聲背景用户具備產科超聲檢查及乳腺病變篩查能力。合作雙方將整合專業優勢與全球先進技術資源,聯合開發並推廣創新型產科及乳腺超聲篩查設備,為降低全球母嬰死亡率的行動提供技術支撐,共同致力於提升中低收入國家的婦女兒童健康水平,通過推動創新醫療成果的全球可及性,加速解決全球母嬰健康難題。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account